VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 300 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2017. The put-call ratio across all filers is 2.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $291,000 | +51.6% | 12,500 | 0.0% | 0.16% | +43.9% |
Q1 2018 | $192,000 | -26.2% | 12,500 | 0.0% | 0.11% | -40.0% |
Q4 2017 | $260,000 | +45.3% | 12,500 | 0.0% | 0.19% | +35.7% |
Q3 2017 | $179,000 | -15.6% | 12,500 | 0.0% | 0.14% | -15.7% |
Q2 2017 | $212,000 | +53.6% | 12,500 | 0.0% | 0.17% | +46.9% |
Q1 2017 | $138,000 | -24.2% | 12,500 | 0.0% | 0.11% | -28.5% |
Q4 2016 | $182,000 | -1.1% | 12,500 | +66.7% | 0.16% | -4.2% |
Q3 2016 | $184,000 | -24.0% | 7,500 | -37.5% | 0.16% | -25.3% |
Q2 2016 | $242,000 | +130.5% | 12,000 | +200.0% | 0.22% | +125.5% |
Q1 2016 | $105,000 | – | 4,000 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |